BioSpace News Archive

FDA

Novaliq’s NovaTears Treatment for Evaporative Dry Eye Disease Launches in New Zealand and Receives Registrational Approval in Australia

NovaTears immediately stabilizes the lipid layer without causing vision blurring.

October 30, 2017

·

4 min read

Deals

Hildred Capital Partners to Invest in Crown Laboratories

Hildred Capital Partners announced that Hildred has entered into an agreement under which it will assume a major stake in Crown Laboratories.

October 30, 2017

·

5 min read

Drug Development

Eyenovia Publication of EYE 102 Phase II Results Demonstrates Strong Pharmacodynamic Effect, Tolerability and Reduced Systemic Exposure of High-Precision Micro-dosing compared to Conventional Eyedroppers

Eyenovia’s micro-dose delivery of topical phenylephrine achieves comparable dilation results with a dose one-quarter the volume of a conventional pipette eye dropper.

October 30, 2017

·

4 min read

Therapix Biosciences Initiates Non-clinical Studies for its Antibacterial Program in Collaboration With the Weizmann Institute of Science and Tel Aviv Sourasky Medical Center

Therapix has initiated non-clinical studies to evaluate the efficacy of its proprietary compound THX-150, a pharma composition of dronabinol in collaboration with the Weizmann Institute of Science and the Tel Aviv Sourasky Medical Center.

October 30, 2017

·

7 min read

Business

Arena to Release Third Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, November 7

Arena, today announced that the Company will release its third quarter 2017 financial results and provide a corporate update on Tuesday, November 7, 2017, after the close of the U.S. financial markets.

October 30, 2017

·

2 min read

Lone Star Bio

Neos Therapeutics Board of Directors Unanimously Rejects Unsolicited Proposal from PDL BioPharma

NEOS Therapeutics today announced that its Board of Directors has unanimously rejected the October 26 unsolicited proposal from PDL BioPharma to acquire all of the outstanding shares of Neos for $10.25 per share in cash.

October 30, 2017

·

5 min read

Business

Antares Vision North America and Xyntek Renew Strategic Partnership for U.S. Sales of Serialization Aggregation Solutions

Antares Vision has renewed its strategic partnership with Xyntek which means that Xyntek will continue to sell and service solutions in the Antares Track System platform throughout the U.S.

October 30, 2017

·

3 min read

Business

Endo Announces Certain Preliminary Financial Results for Third-Quarter 2017 and Affirms Selected 2017 Financial Guidance

Endo International today announced certain preliminary results for the quarter ended September 30, 2017 and also affirmed that for the twelve months ending December 31, 2017, the Company expects revenues to be between $3.38B and $3.53B.

October 30, 2017

·

15 min read

Business

Theravance Biopharma to Report Third Quarter 2017 Financial Results on November 7, 2017

Theravance Biopharma today announced that it will release financial results for the period ended September 30, 2017 after market close on Tuesday, November 7, 2017.

October 30, 2017

·

3 min read

Business

Infinity Announces the Date of its Third Quarter 2017 Financial Results Conference Call and Webcast

Infinity Pharma will host a conference call on Tuesday, November 7, 2017, at 4:30 p.m. ET to review its third quarter 2017 financial results and provide an update on the company.

October 30, 2017

·

1 min read